Form 4: Recursion Pharmaceuticals Chief Medical Officer David J. Mauro Reports Stock Transaction

David J. Mauro, Chief Medical Officer of Recursion Pharmaceuticals, sold 4,187 shares of Class A Common Stock to cover tax obligations related to restricted stock units.

Summary

• David J. Mauro, the Chief Medical Officer of Recursion Pharmaceuticals, reported a transaction involving the company's stock.
• On November 15, 2024, Mr. Mauro disposed of 4,187 shares of Class A Common Stock at a price of $6.175 per share.
• This transaction was to cover tax withholding obligations related to the net settlement of restricted stock units.
• Following the transaction, Mr. Mauro directly owns 225,429 shares of Class A Common Stock.
• Mr. Mauro also holds stock options for 99,537 shares at an exercise price of $10.09 and 381,426 shares at an exercise price of $8.77.

Sentiment

Score: 5

Explanation: The document is a routine filing of an insider transaction and does not indicate any positive or negative sentiment. It is a neutral event.

Industry Context

This is a routine filing for insider transactions and is common for executives who receive stock-based compensation. It does not indicate any specific trend in the pharmaceutical industry.

Comparison to Industry Standards

• Stock transactions by executives are a common occurrence in publicly traded companies, especially in the biotech and pharmaceutical sectors.
• The sale of shares to cover tax obligations is a standard practice when restricted stock units vest.
• The vesting schedules for the stock options are typical for executive compensation packages.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale of shares by an executive.
• The transaction does not impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Recursion Pharmaceuticals, David J. Mauro, stock transaction, Form 4, insider trading, Class A Common Stock, stock options, restricted stock units, tax withholding